نتایج جستجو برای: cyp51a

تعداد نتایج: 195  

Journal: :Antimicrobial agents and chemotherapy 2010
Eleftheria Mavridou Roger J M Bruggemann Willem J G Melchers Paul E Verweij Johan W Mouton

The in vivo efficacy of voriconazole against 4 clinical Aspergillus fumigatus isolates with MICs ranging from 0.125 to 2 mg/liter (CLSI document M38A) was assessed in a nonneutropenic murine model of disseminated aspergillosis. The study involved TR/L98H, M220I, and G54W mutants and a wild-type control isolate. Oral voriconazole therapy was started 24 h after intravenous infection of mice and w...

Journal: :The Journal of antimicrobial chemotherapy 2011
P E Verweij S M T Camps G H J Kema W J G Melchers

Sir, Azole resistance is an emerging clinical problem in patients with Aspergillus infections, primarily those caused by Aspergillus fumigatus. Alanio et al. describe the results of a study that investigated the prevalence of azole resistance in 118 clinical Aspergillus isolates obtained from a cohort of 89 patients with haematological malignancy. They found only one azole-resistant A. fumigatu...

2015
Anuradha Chowdhary Cheshta Sharma Shallu Kathuria Ferry Hagen Jacques F. Meis

Aspergillus fumigatus causes varied clinical syndromes ranging from colonization to deep infections. The mainstay of therapy of Aspergillus diseases is triazoles but several studies globally highlighted variable prevalence of triazole resistance, which hampers the management of aspergillosis. We studied the prevalence of resistance in clinical A. fumigatus isolates during 4 years in a referral ...

Journal: :Journal of clinical microbiology 2010
A Espinel-Ingroff D J Diekema A Fothergill E Johnson T Pelaez M A Pfaller M G Rinaldi E Canton J Turnidge

Clinical breakpoints have not been established for mold testing. Wild-type (WT) MIC distributions (organisms in a species/drug combination with no detectable acquired resistance mechanisms) were defined in order to establish epidemiologic cutoff values (ECVs) for five Aspergillus spp. and itraconazole, posaconazole, and voriconazole. Also, we have expanded prior ECV data for Aspergillus fumigat...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013
Jan W M van der Linden Simone M T Camps Greetje A Kampinga Jan P A Arends Yvette J Debets-Ossenkopp Pieter J A Haas Bart J A Rijnders Ed J Kuijper Frank H van Tiel János Varga Anna Karawajczyk J Zoll Willem J G Melchers Paul E Verweij

BACKGROUND Azole resistance is an emerging problem in Aspergillus fumigatus and complicates the management of patients with Aspergillus-related diseases. Selection of azole resistance may occur through exposure to azole fungicides in the environment. In the Netherlands a surveillance network was used to investigate the epidemiology of resistance selection in A. fumigatus. METHODS Clinical A. ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید